logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Advanced Centre for Treatment Research and Education in Cancer (ACTREC)

Verified

Basic Information

Site Overview

Source: Human-provided.

The Advanced Centre for Treatment, Research & Education in Cancer (ACTREC) is a premier cancer research and treatment institute located in Kharghar, Navi Mumbai, Maharashtra, India. It functions as the research and academic arm of the Tata Memorial Centre (TMC), a grant-in-aid institution under the Department of Atomic Energy, Government of India. ACTREC’s mandate encompasses comprehensive cancer research, advanced therapeutic services and education, integrating basic science with clinical oncology to develop new diagnostics, targeted therapies and evidence-based treatment approaches. The centre is set amid the scenic foothills of the Sahyadri mountains and houses state-of-the-art laboratories and cutting-edge research infrastructure dedicated to unraveling cancer biology and improving patient outcomes. ACTREC also offers PhD programs and collaborative training in life sciences and oncology research, contributing significantly to cancer science in India. It serves as both a…

Source: Trial-derived.
20Total Trials
Source: Trial-derived.
10Recruiting Trials
Source: Trial-derived.
13Active Trials
Source: Trial-derived.
6Completed Trials
Source: Trial-derived.
32Unique Conditions
Source: Trial-derived.
9Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. Cervical Cancer (3)Source: Trial-derived. Endometrial Cancer (2)Source: Trial-derived. Acute Leukemia (1)Source: Trial-derived. Advanced Solid Tumor (1)Source: Trial-derived. Cancer Cervix (1)Source: Trial-derived. Carcinoma, Hepatocellular (1)Source: Trial-derived. Carcinoma, Non-Small-Cell Lung (1)Source: Trial-derived. Cervix Cancer (1)

Sponsors

Source: Trial-derived. Tata Memorial Hospital (12)Source: Trial-derived. Tata Memorial Centre (4)Source: Trial-derived. Bhabha Atomic Research Centre (1)Source: Trial-derived. Dr.Pankaj Chaturvedi (1)Source: Trial-derived. Eli Lilly and Company (1)Source: Trial-derived. Erasmus Medical Center (1)Source: Trial-derived. Godavari Biorefineries Limited (1)Source: Trial-derived. Pfizer (1)

Trial Phases

Historical Trial Phase Experience

Source: Human-provided. Phase I
Source: Human-provided. Phase II
Source: Human-provided. Phase III
Source: Human-provided. Phase IV

Dedicated Phase 1 Unit

Source: Human-provided. Yes

Research Team & Staffing

Research team size (total staff)

Source: Human-provided. 31

Principal investigators

Source: Human-provided. 20

Study coordinators

Source: Human-provided. 4

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. Timed pharmacokinetic sampling and processing

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling
Source: AI-inferred. Sterile preparation (laminar-flow hood / BSC or cleanroom)

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration